Eggermont AM, Suciu S, Testori A, Kruit WH, Marsden J, Punt CJ, et al. Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer 2012 Jan;48(2):218-25 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22056637.
Compare quality appraisals for each clinical question
- What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?